1 Market Overview of Neuropathic Pain Therapeutics
1.1 Neuropathic Pain Therapeutiarket Overview
1.1.1 Neuropathic Pain Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Neuropathic Pain Therapeutiarket Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Neuropathic Pain Therapeutiarket Size by Region (2015-2026)
1.4 Global Neuropathic Pain Therapeutics Historic Market Size by Region (2015-2020)
1.5 Global Neuropathic Pain Therapeutiarket Size Forecast by Region (2021-2026)
1.6 Key Regions, Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026)
1.6.1 North America Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026)
1.6.2 Europe Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026)
1.6.4 Latin America Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026)
2 Neuropathic Pain Therapeutiarket Overview by Type
2.1 Global Neuropathic Pain Therapeutiarket Size by Type: 2015 VS 2020 VS 2026
2.2 Global Neuropathic Pain Therapeutics Historic Market Size by Type (2015-2020)
2.3 Global Neuropathic Pain Therapeutics Forecasted Market Size by Type (2021-2026)
2.4 Anticonvulsants
2.5 Antidepressants
2.6 NSAIDs
2.7 Opioids
2.8 Steroids
2.9 Others
3 Neuropathic Pain Therapeutiarket Overview by Application
3.1 Global Neuropathic Pain Therapeutiarket Size by Application: 2015 VS 2020 VS 2026
3.2 Global Neuropathic Pain Therapeutics Historic Market Size by Application (2015-2020)
3.3 Global Neuropathic Pain Therapeutics Forecasted Market Size by Application (2021-2026)
3.4 Diabetic Neuropathy
3.5 Chemotherapy-Induced Neuropathy Pain
3.6 Postherpetic Neuralgia
3.7 Spinal Cord Injury
3.8 Others
4 Global Neuropathic Pain Therapeutics Competition Analysis by Players
4.1 Global Neuropathic Pain Therapeutiarket Size by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropathic Pain Therapeutics as of 2019)
4.3 Date of Key Manufacturers Enter into Neuropathic Pain Therapeutiarket
4.4 Global Top Players Neuropathic Pain Therapeutics Headquarters and Area Served
4.5 Key Players Neuropathic Pain Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Neuropathic Pain Therapeutiarket Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Company 1
5.1.1 Company 1 Profile
5.1.2 Company 1 Main Business
5.1.3 Company 1 Neuropathic Pain Therapeutics Products, Services and Solutions
5.1.4 Company 1 Neuropathic Pain Therapeutics Revenue (US$ Million) & (2015-2020)
5.1.5 Company 1 Recent Developments
5.2 Company 2
5.2.1 Company 2 Profile
5.2.2 Company 2 Main Business
5.2.3 Company 2 Neuropathic Pain Therapeutics Products, Services and Solutions
5.2.4 Company 2 Neuropathic Pain Therapeutics Revenue (US$ Million) & (2015-2020)
5.2.5 Company 2 Recent Developments
5.3 Company 3
5.5.1 Company 3 Profile
5.3.2 Company 3 Main Business
5.3.3 Company 3 Neuropathic Pain Therapeutics Products, Services and Solutions
5.3.4 Company 3 Neuropathic Pain Therapeutics Revenue (US$ Million) & (2015-2020)
5.3.5 Company 4 Recent Developments
5.4 Company 4
5.4.1 Company 4 Profile
5.4.2 Company 4 Main Business
5.4.3 Company 4 Neuropathic Pain Therapeutics Products, Services and Solutions
5.4.4 Company 4 Neuropathic Pain Therapeutics Revenue (US$ Million) & (2015-2020)
5.4.5 Company 4 Recent Developments
5.5 Company 5
5.5.1 Company 5 Profile
5.5.2 Company 5 Main Business
5.5.3 Company 5 Neuropathic Pain Therapeutics Products, Services and Solutions
5.5.4 Company 5 Neuropathic Pain Therapeutics Revenue (US$ Million) & (2015-2020)
5.5.5 Company 5 Recent Developments
5.6 Company 6
5.6.1 Company 6 Profile
5.6.2 Company 6 Main Business
5.6.3 Company 6 Neuropathic Pain Therapeutics Products, Services and Solutions
5.6.4 Company 6 Neuropathic Pain Therapeutics Revenue (US$ Million) & (2015-2020)
5.6.5 Company 6 Recent Developments
5.7 Company 7
5.7.1 Company 7 Profile
5.7.2 Company 7 Main Business
5.7.3 Company 7 Neuropathic Pain Therapeutics Products, Services and Solutions
5.7.4 Company 7 Neuropathic Pain Therapeutics Revenue (US$ Million) & (2015-2020)
5.7.5 Company 7 Recent Developments
5.8 Company 8
5.8.1 Company 8 Profile
5.8.2 Company 8 Main Business
5.8.3 Company 8 Neuropathic Pain Therapeutics Products, Services and Solutions
5.8.4 Company 8 Neuropathic Pain Therapeutics Revenue (US$ Million) & (2015-2020)
5.8.5 Company 8 Recent Developments
5.9 Company 9
5.9.1 Company 9 Profile
5.9.2 Company 9 Main Business
5.9.3 Company 9 Neuropathic Pain Therapeutics Products, Services and Solutions
5.9.4 Company 9 Neuropathic Pain Therapeutics Revenue (US$ Million) & (2015-2020)
5.9.5 Company 9 Recent Developments
5.10 Company 10
5.10.1 Company 10 Profile
5.10.2 Company 10 Main Business
5.10.3 Company 10 Neuropathic Pain Therapeutics Products, Services and Solutions
5.10.4 Company 10 Neuropathic Pain Therapeutics Revenue (US$ Million) & (2015-2020)
5.10.5 Company 10 Recent Developments
5.11 Company 11
5.11.1 Company 11 Profile
5.11.2 Company 11 Main Business
5.11.3 Company 11 Neuropathic Pain Therapeutics Products, Services and Solutions
5.11.4 Company 11 Neuropathic Pain Therapeutics Revenue (US$ Million) & (2015-2020)
5.11.5 Company 11 Recent Developments
6 North America
6.1 North America Neuropathic Pain Therapeutiarket Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Neuropathic Pain Therapeutiarket Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Neuropathic Pain Therapeutiarket Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Neuropathic Pain Therapeutiarket Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Neuropathic Pain Therapeutiarket Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Neuropathic Pain Therapeutiarket Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
全球神經性疼痛治療市場研究與趨勢分析報告2020-2026
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
Table 1. Global Market Neuropathic Pain Therapeutiarket Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026
Table 2. Global Neuropathic Pain Therapeutiarket Size by Region (2015-2020) (US$ Million)
Table 3. Global Neuropathic Pain Therapeutiarket Size Share by Region (2015-2020)
Table 4. Global Neuropathic Pain Therapeutics Forecasted Market Size by Region (2021-2026) (US$ Million)
Table 5. Global Neuropathic Pain Therapeutics Forecasted Market Size Share by Region (2021-2026)
Table 6. Global Neuropathic Pain Therapeutiarket Size (US$ Million) by Type: 2015 VS 2020 VS 2026
Table 7. Global Neuropathic Pain Therapeutiarket Size by Type (2015-2020) (US$ Million)
Table 8. Global Neuropathic Pain Therapeutics Revenue Market Share by Type (2015-2020)
Table 9. Global Neuropathic Pain Therapeutics Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 10. Global Neuropathic Pain Therapeutics Revenue Market Share by Type (2021-2026)
Table 11. Global Neuropathic Pain Therapeutiarket Size (US$ Million) by Application: 2015 VS 2020 VS 2026
Table 12. Global Neuropathic Pain Therapeutiarket Size by Application (2015-2020) (US$ Million)
Table 13. Global Neuropathic Pain Therapeutics Revenue Market Share by Application (2015-2020)
Table 14. Global Neuropathic Pain Therapeutics Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 15. Global Neuropathic Pain Therapeutics Revenue Market Share by Application (2021-2026)
Table 16. Global Neuropathic Pain Therapeutics Revenue (US$ Million) by Players (2015-2020)
Table 17. Global Neuropathic Pain Therapeutics Revenue Market Share by Players (2015-2020)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropathic Pain Therapeutics as of 2019)
Table 19. Date of Key Manufacturers Enter into Neuropathic Pain Therapeutiarket
Table 20. Global Neuropathic Pain Therapeutics Top Players Headquarters and Area Served
Table 21. Neuropathic Pain Therapeutics Product Solution and Service
Table 22. Global Neuropathic Pain Therapeutianufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Company 1 Basic Information List
Table 25. Company 1 Description and Business Overview
Table 26. Company 1 Neuropathic Pain Therapeutics Products, Services and Solutions
Table 27. Revenue (Million US$) in Neuropathic Pain Therapeutics Business of Company 1 (2015-2020)
Table 28. Company 1 Recent Developments
Table 29. Company 2 Basic Information List
Table 30. Company 2 Description and Business Overview
Table 31. Company 2 Neuropathic Pain Therapeutics Products, Services and Solutions
Table 32. Revenue (Million US$) in Neuropathic Pain Therapeutics Business of Company 2 (2015-2020)
Table 33. Company 2 Recent Developments
Table 34. Company 3 Basic Information List
Table 35. Company 3 Description and Business Overview
Table 36. Company 3 Neuropathic Pain Therapeutics Products, Services and Solutions
Table 37. Revenue (Million US$) in Neuropathic Pain Therapeutics Business of Company 3 (2015-2020)
Table 38. Company 3 Recent Developments
Table 39. Company 4 Basic Information List
Table 40. Company 4 Description and Business Overview
Table 41. Company 4 Neuropathic Pain Therapeutics Products, Services and Solutions
Table 42. Revenue (Million US$) in Neuropathic Pain Therapeutics Business of Company 4 (2015-2020)
Table 43. Company 4 Recent Developments
Table 44. Company 5 Basic Information List
Table 45. Company 5 Description and Business Overview
Table 46. Company 5 Neuropathic Pain Therapeutics Products, Services and Solutions
Table 47. Revenue (Million US$) in Neuropathic Pain Therapeutics Business of Company 5 (2015-2020)
Table 48. Company 5 Recent Developments
Table 49. Company 6 Basic Information List
Table 50. Company 6 Description and Business Overview
Table 51. Company 6 Neuropathic Pain Therapeutics Products, Services and Solutions
quánqiú shénjīng xìng téngtòng zhìliáoshìchǎng yánjiū yǔ qūshì fēnxī bàogào 2020-2026
Table 52. Revenue (Million US$) in Neuropathic Pain Therapeutics Business of Company 6 (2015-2020)
Table 53. Company 6 Recent Developments
Table 54. Company 7 Basic Information List
Table 55. Company 7 Description and Business Overview
Table 56. Company 7 Neuropathic Pain Therapeutics Products, Services and Solutions
Table 57. Revenue (Million US$) in Neuropathic Pain Therapeutics Business of Company 7 (2015-2020)
Table 58. Company 7 Recent Developments
Table 59. Company 8 Basic Information List
Table 60. Company 8 Description and Business Overview
Table 61. Company 8 Neuropathic Pain Therapeutics Products, Services and Solutions
Table 62. Revenue (Million US$) in Neuropathic Pain Therapeutics Business of Company 8 (2015-2020)
Table 63. Company 8 Recent Developments
Table 64. Company 9 Basic Information List
Table 65. Company 9 Description and Business Overview
Table 66. Company 9 Neuropathic Pain Therapeutics Products, Services and Solutions
Table 67. Revenue (Million US$) in Neuropathic Pain Therapeutics Business of Company 9 (2015-2020)
Table 68. Company 9 Recent Developments
Table 69. Company 10 Basic Information List
Table 70. Company 10 Description and Business Overview
Table 71. Company 10 Neuropathic Pain Therapeutics Products, Services and Solutions
Table 72. Revenue (Million US$) in Neuropathic Pain Therapeutics Business of Company 10 (2015-2020)
Table 73. Company 10 Recent Developments
Table 74. Company 11 Basic Information List
Table 75. Company 11 Description and Business Overview
Table 76. Company 11 Neuropathic Pain Therapeutics Products, Services and Solutions
Table 77. Revenue (Million US$) in Neuropathic Pain Therapeutics Business of Company 11 (2015-2020)
Table 78. Company 11 Recent Developments
Table 79. North America Neuropathic Pain Therapeutiarket Size by Country (2015-2020) & (US$ Million)
Table 80. North America Neuropathic Pain Therapeutiarket Size Share by Country (2015-2020)
Table 81. Europe Neuropathic Pain Therapeutiarket Size by Country (2015-2020) & (US$ Million)
Table 82. Europe Neuropathic Pain Therapeutiarket Size Share by Country (2015-2020)
Table 83. Asia-Pacific Neuropathic Pain Therapeutiarket Size by Region (2015-2020) & (US$ Million)
Table 84. Asia-Pacific Neuropathic Pain Therapeutiarket Size Share by Region (2015-2020) (US$ Million)
Table 85. Latin America Neuropathic Pain Therapeutiarket Size by Country (2015-2020) & (US$ Million)
Table 86. Latin America Neuropathic Pain Therapeutiarket Size Share by Country (2015-2020) (US$ Million)
Table 87. Middle East & Africa Neuropathic Pain Therapeutiarket Size by Players (2015-2020) (US$ Million)
Table 88. Middle East & Africa Neuropathic Pain Therapeutiarket Size Share by Players (2015-2020) (US$ Million)
Table 89. Neuropathic Pain Therapeutiarket Trends
Table 90. Neuropathic Pain Therapeutiarket Drivers
Table 91. Neuropathic Pain Therapeutiarket Challenges
Table 92. Neuropathic Pain Therapeutiarket Restriants
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuropathic Pain Therapeutiarket Size Year-over-Year 2015-2026 & (US$ Million)
Figure 2. Global Neuropathic Pain Therapeutiarket Size (US$ Million), 2015 VS 2020VS 2026
Figure 3. Global Neuropathic Pain Therapeutiarket Share by Regions: 2020 VS 2026
Figure 4. North America Neuropathic Pain Therapeutiarket Size (US$ Million) Growth Rate (2015-2026)
Figure 5. Europe Neuropathic Pain Therapeutiarket Size (US$ Million) and Growth Rate (2015-2026)
Figure 6. Asia-Pacific Neuropathic Pain Therapeutiarket Size (US$ Million) and Growth Rate (2015-2026)
Figure 7. Latin America Neuropathic Pain Therapeutiarket Size (US$ Million) and Growth Rate (2015-2026)
Figure 8. Middle East & Africa Neuropathic Pain Therapeutiarket Size (US$ Million) and Growth Rate (2015-2026)
Figure 9. Global Neuropathic Pain Therapeutiarket Share by Type in 2020 & 2026
Figure 10. Anticonvulsants Market Size (US$ Million) YoY Growth (2015-2026)
Figure 11. Antidepressants Market Size (US$ Million) YoY Growth (2015-2026)
Figure 12. NSAIDs Market Size (US$ Million) YoY Growth (2015-2026)
Figure 13. Opioids Market Size (US$ Million) YoY Growth (2015-2026)
Figure 14. Steroids Market Size (US$ Million) YoY Growth (2015-2026)
Figure 15. Others Market Size (US$ Million) YoY Growth (2015-2026)
世界の神経因性疼痛治療薬市場調査と動向分析報告書2020-2026
Figure 16. Global Neuropathic Pain Therapeutiarket Size Share by Application in 2020 & 2026
Figure 17. Diabetic Neuropathy Market Size (US$ Million) YoY Growth (2015-2026)
Figure 18. Chemotherapy-Induced Neuropathy Pain Market Size (US$ Million) YoY Growth (2015-2026)
Figure 19. Postherpetic Neuralgia Market Size (US$ Million) YoY Growth (2015-2026)
Figure 20. Spinal Cord Injury Market Size (US$ Million) YoY Growth (2015-2026)
Figure 21. Others Market Size (US$ Million) YoY Growth (2015-2026)
Figure 22. Neuropathic Pain Therapeutiarket Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Top 5 and Top 10 Players Neuropathic Pain Therapeutiarket Share in 2019
Figure 24. United States Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Canada Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Germany Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. France Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. U.K. Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Italy Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Russia Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Nordic Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Rest of Europe Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. China Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Japan Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. South Korea Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Southeast Asia Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. India Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Australia Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Rest of Asia-Pacific Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Mexico Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Brazil Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Latin America Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Turkey Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Saudi Arabia Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. UAE Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Rest of Middle East & Africa Neuropathic Pain Therapeutiarket Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
略……
請您致電:400 612 8668、010-6618 1099、66182099、66183099
或Email至:KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”